Physician profile
Margaret E Bates
NPI 1407956527
$905.69
in general payments reported to CMS, 2019-2025
12 companies · $68.14 in 2025
The $68.14 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $127 · 2024: $185 · 2025: $68.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $199.94 | 2019-2020 | |
| Shockwave Medical, INC | $164.71 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Therapeuticsmd, INC. | $132.07 | 2019-2020 | |
| Avion Pharmaceuticals | $126.65 | 2019-2020 | |
| Hologic Sales and Service, LLC | $96.86 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $38.93 | 2019-2025 | Gardasil 9 |
| Coloplast Corp | $37.90 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.31 | 2019 | |
| Allergan, INC. | $22.05 | 2020 | |
| Sanofi Pasteur INC. | $20.88 | 2019 | |
| Astellas Pharma US INC | $20.71 | 2024 | Veozah |
| Vertical Pharmaceuticals, LLC | $17.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Bates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.